146 related articles for article (PubMed ID: 38012185)
1. Early detection of brain metastases and appropriate local therapy followed by systemic chemotherapy may improve the prognosis of gastric cancer.
Ishizuka Y; Omori T; Shinno N; Yamamoto M; Hara H; Otsuka T; Nishio M; Nishida N; Fujisawa F; Sugimoto N; Yagi T; Goto M; Nishikawa H; Kudo T
Sci Rep; 2023 Nov; 13(1):20805. PubMed ID: 38012185
[TBL] [Abstract][Full Text] [Related]
2. A population-based study on treatment and outcomes in patients with gastric adenocarcinoma diagnosed with distant interval metastases.
Dijksterhuis WPM; Kroese TE; Verhoeven RHA; van Rossum PSN; Mook S; Haj Mohammad N; Hulshof MCCM; Gisbertz SS; Ruurda JP; van Oijen MGH; van Hillegersberg R; van Laarhoven HWM
Eur J Surg Oncol; 2022 Sep; 48(9):1964-1971. PubMed ID: 35314096
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas.
Liu DJ; Fu XL; Liu W; Zheng LY; Zhang JF; Huo YM; Li J; Hua R; Liu Q; Sun YW
World J Gastroenterol; 2017 Jan; 23(3):516-524. PubMed ID: 28210088
[TBL] [Abstract][Full Text] [Related]
4. Survival of gastric cancer with concomitant liver metastases.
Kwok CM; Wu CW; Lo SS; Shen KH; Hsieh MC; Lui WY
Hepatogastroenterology; 2004; 51(59):1527-30. PubMed ID: 15362793
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for ovarian metastases from primary gastric cancer.
Wang J; Shi YK; Wu LY; Wang JW; Yang S; Yang JL; Zhang HZ; Liu SM
Int J Gynecol Cancer; 2008; 18(4):825-32. PubMed ID: 17892453
[TBL] [Abstract][Full Text] [Related]
6. Long-term trastuzumab (Herceptin®) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer.
Müller V; Clemens M; Jassem J; Al-Sakaff N; Auclair P; Nüesch E; Holloway D; Shing M; Bang YJ
BMC Cancer; 2018 Mar; 18(1):295. PubMed ID: 29544445
[TBL] [Abstract][Full Text] [Related]
7. Prognostic analysis and liver metastases relevant factors after gastric and hepatic surgical treatment in gastric cancer patients with metachronous liver metastases: a population-based study.
Xiao Y; Zhang B; Wu Y
Ir J Med Sci; 2019 May; 188(2):415-424. PubMed ID: 30062399
[TBL] [Abstract][Full Text] [Related]
8. [Clinical outcomes in patients with brain metastasis from gastric cancer].
Tamura S; Takeno A; Miki H; Uchiyama C; Kanemura T; Ono H; Hamanaka M; Suzuki R; Nakahira S; Nakata K; Takeda Y
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2093-6. PubMed ID: 22202294
[TBL] [Abstract][Full Text] [Related]
9. Survival outcomes in patients with gastric and gastroesophageal junction adenocarcinomas treated with perioperative chemotherapy with or without preoperative radiotherapy.
Tian S; Jiang R; Madden NA; Ferris MJ; Buchwald ZS; Xu KM; Cardona K; Maithel SK; McDonald MW; Lin JY; Curran WJ; El-Rayes BF; Behera M; Patel PR
Cancer; 2020 Jan; 126(1):37-45. PubMed ID: 31532544
[TBL] [Abstract][Full Text] [Related]
10. Real-world clinical outcomes of the combination of anti-PD-1 antibody, trastuzumab, and chemotherapy for HER2-positive gastric/gastroesophageal junction cancer.
Yang J; Shi Z; Zhang X; Liu Q; Cui X; Li L; Liu B; Wei J
Cancer Med; 2023 Apr; 12(8):9517-9526. PubMed ID: 36912199
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and predictive value of mismatch repair deficiency in gastric and gastroesophageal junction adenocarcinoma patients receiving neoadjuvant or adjuvant chemotherapy.
Li Z; Wang Y; Ying X; Zhang L; Gao X; Jia Y; Zhang L; Wu A; Su X; Ji J
J Surg Oncol; 2021 Dec; 124(8):1356-1364. PubMed ID: 34515995
[TBL] [Abstract][Full Text] [Related]
12. Role of repeat staging laparoscopy in locoregionally advanced gastric or gastroesophageal cancer after neoadjuvant therapy.
Cardona K; Zhou Q; Gönen M; Shah MA; Strong VE; Brennan MF; Coit DG
Ann Surg Oncol; 2013 Feb; 20(2):548-54. PubMed ID: 22941159
[TBL] [Abstract][Full Text] [Related]
13. [Clinical features and prognostic factors of brain metastasis from colorectal cancer].
Sun Z; Sun Y; Tan L; He J; Li X; She C; Li W
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):63-8. PubMed ID: 26796809
[TBL] [Abstract][Full Text] [Related]
14. Brain metastases in patients diagnosed with a solid primary cancer during childhood: experience from a single referral cancer center.
Suki D; Khoury Abdulla R; Ding M; Khatua S; Sawaya R
J Neurosurg Pediatr; 2014 Oct; 14(4):372-85. PubMed ID: 25127097
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathologic characteristics and prognosis of gastric hepatoid adenocarcinoma].
Zhao R; Wang X; Lan X; Li M
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1035-1039. PubMed ID: 28900996
[TBL] [Abstract][Full Text] [Related]
16. Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma.
Fields RC; Strong VE; Gönen M; Goodman KA; Rizk NP; Kelsen DP; Ilson DH; Tang LH; Brennan MF; Coit DG; Shah MA
Br J Cancer; 2011 Jun; 104(12):1840-7. PubMed ID: 21610705
[TBL] [Abstract][Full Text] [Related]
17. Surgical management of single and multiple brain metastases: results of a retrospective study.
Schackert G; Steinmetz A; Meier U; Sobottka SB
Onkologie; 2001 Jun; 24(3):246-55. PubMed ID: 11455217
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pathological study of gastric cancer with ovarian metastasis.
Kobayashi O; Sugiyama Y; Cho H; Tsuburaya A; Sairenji M; Motohashi H; Yoshikawa T
Int J Clin Oncol; 2003 Apr; 8(2):67-71. PubMed ID: 12720097
[TBL] [Abstract][Full Text] [Related]
19. Current state of surgical treatment of cancer of the stomach and gastro-esophageal junction in the Czech Republic.
Duda M; Dušek L; Jínek T; Adamčík L; Škrovina M
Rozhl Chir; 2018; 97(7):309-319. PubMed ID: 30442012
[TBL] [Abstract][Full Text] [Related]
20. The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI.
Al-Batran SE; Goetze TO; Mueller DW; Vogel A; Winkler M; Lorenzen S; Novotny A; Pauligk C; Homann N; Jungbluth T; Reissfelder C; Caca K; Retter S; Horndasch E; Gumpp J; Bolling C; Fuchs KH; Blau W; Padberg W; Pohl M; Wunsch A; Michl P; Mannes F; Schwarzbach M; Schmalenberg H; Hohaus M; Scholz C; Benckert C; Knorrenschild JR; Kanngießer V; Zander T; Alakus H; Hofheinz RD; Roedel C; Shah MA; Sasako M; Lorenz D; Izbicki J; Bechstein WO; Lang H; Moenig SP
BMC Cancer; 2017 Dec; 17(1):893. PubMed ID: 29282088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]